Dr. Eric Belin de Chantemele: Advancing Cardiovascular Research with a Focus on Women’s Health

Dr. Eric Belin de Chantemele, a Professor of Medicine at the Vascular Biology Center at Augusta University, has dedicated his research to understanding the complex relationship between obesity, hypertension, and cardiovascular disease, particularly in women. His work explores how lipid deficiency and lipo-dystrophy in mice impact vascular function, with a specific focus on how the absence of fat affects cardiac health. Interestingly, his initial research was inspired by studying the effects of spaceflight on cardiac disease in mice, which eventually led him to uncover critical insights about obesity-related hypertension.

One of Dr. Belin de Chantemele’s most surprising discoveries came while working with a mouse model deficient in alpha-1B receptors. When he ran out of male mice and had to shift focus to female mice, he discovered that female mice displayed worse vascular function. This finding was unexpected but he believed in the data, which led to his groundbreaking research on leptin, a hormone that regulates estrogen—resulting in his most cited paper to date.

His research holds immense promise for the future, with the ultimate goal of developing targeted treatments for cardiovascular disease in women. Dr. Belin de Chantemele hopes that his work will lead to more personalized therapies that address the unique cardiovascular challenges faced by women, closing the gap in treatment outcomes.

A long-time user of DMT equipment from his postdoc in France, Dr. Belin de Chantemele praises the reliability and ease of use of the systems, noting that his lab operates seven DMT wire systems daily. This dependable technology has been instrumental in facilitating his research and ensuring consistent results.

When reflecting on his career, Dr. Belin de Chantemele is most proud of the impact he’s had on the next generation of researchers. Many of his trainees have transitioned to faculty positions, received prestigious awards, and, in 2024 alone, three of his students were awarded fellowships while another three secured R01 grants.

Like many in his field, Dr. Belin de Chantemele faced significant challenges early in his career, particularly in securing his first R01 grant, which took three submission cycles to obtain. His advice to aspiring researchers is simple yet powerful: “Be persistent, believe in your data, and don’t be afraid to fail.”
​
Through his commitment to research, mentorship, and innovation, Dr. Belin de Chantemele continues to shape the scientific community and pave the way for future breakthroughs in cardiovascular health.